Editing the epigenome: technologies for programmable transcription and epigenetic modulation

Nature Methods
Pratiksha I ThakoreCharles A Gersbach

Abstract

Gene regulation is a complex and tightly controlled process that defines cell identity, health and disease, and response to pharmacologic and environmental signals. Recently developed DNA-targeting platforms, including zinc finger proteins, transcription activator-like effectors (TALEs) and the clustered, regularly interspaced, short palindromic repeats (CRISPR)-Cas9 system, have enabled the recruitment of transcriptional modulators and epigenome-modifying factors to any genomic site, leading to new insights into the function of epigenetic marks in gene expression. Additionally, custom transcriptional and epigenetic regulation is facilitating refined control over cell function and decision making. The unique properties of the CRISPR-Cas9 system have created new opportunities for high-throughput genetic screens and multiplexing targets to manipulate complex gene expression patterns. This Review summarizes recent technological developments in this area and their application to biomedical challenges. We also discuss remaining limitations and necessary future directions for this field.

References

May 27, 1997·Proceedings of the National Academy of Sciences of the United States of America·Q LiuC F Barbas
Feb 8, 2000·Proceedings of the National Academy of Sciences of the United States of America·R R BeerliC F Barbas
Nov 5, 2002·Nature Medicine·Edward J RebarFrank J Giordano
Dec 25, 2002·Current Biology : CB·Andrew W SnowdenCarl O Pabo
Feb 20, 2003·Nature Biotechnology·Pilar BlancafortCarlos F Barbas
Sep 30, 2003·Proceedings of the National Academy of Sciences of the United States of America·Siyuan TanPhilip D Gregory
Dec 24, 2003·Molecular Cell·Antoine H F M PetersThomas Jenuwein
May 25, 2006·Annual Review of Genomics and Human Genetics·Glenn A MastonMichael R Green
Aug 1, 2006·Nature Structural & Molecular Biology·Yali DouRobert G Roeder
Aug 19, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Katsutoshi YokoiPeter A Campochiaro
Nov 7, 2007·Nature Structural & Molecular Biology·Sukesh R BhaumikAli Shilatifard
Mar 12, 2008·Proceedings of the National Academy of Sciences of the United States of America·Gregory DavidRonald A Depinho
Jul 1, 2009·Cell·Jennifer E Phillips, Victor G Corces
Nov 26, 2009·Science·Matthew J Moscou, Adam J Bogdanove
Dec 4, 2009·Nature·Thomas Graf, Tariq Enver
Jul 21, 2010·Nature·K KimG Q Daley
Oct 15, 2010·Nature Biotechnology·Theresa K KellyPeter A Jones
Nov 3, 2010·Nature Methods·Matthew J KennedyChandra L Tucker

❮ Previous
Next ❯

Citations

Jan 13, 2016·Molecular Therapy : the Journal of the American Society of Gene Therapy·Morgan L Maeder, Charles A Gersbach
Mar 11, 2016·Nature Biotechnology·Christopher E Nelson, Charles A Gersbach
Mar 30, 2016·Human Gene Therapy·Jorge Mansilla-SotoMichel Sadelain
May 24, 2016·Nature Methods·Alejandro ChavezGeorge Church
Jun 28, 2016·Briefings in Functional Genomics·Raul Torres-Ruiz, Sandra Rodriguez-Perales
Aug 9, 2016·Proceedings of the National Academy of Sciences of the United States of America·David M MacAlpine
Nov 1, 2016·Nature Reviews. Genetics·Benjamin E HousdenNorbert Perrimon
Jan 11, 2017·Journal of Dental Research·Z WangM J Passineau
May 13, 2017·Nature Communications·Deborah Y KwonZhaolan Zhou
May 16, 2017·Epigenetics & Chromatin·Masahiro OkadaAkihiko Yoshimura
May 14, 2016·Journal of Genetics and Genomics = Yi Chuan Xue Bao·Daniel F Voytas
Jun 2, 2017·Nature Reviews. Rheumatology·Stephen EyreJane Worthington
Jan 24, 2017·Nature Reviews. Microbiology·Sergey ShmakovEugene V Koonin
Apr 6, 2018·Nature Biotechnology·Markus Elsner
Apr 13, 2018·Genes·Kristie BloomPatrick Arbuthnot
Apr 17, 2018·Human Molecular Genetics·Cui ZhangJinfu Wang
May 3, 2018·Physiological Reviews·Yu ZhangEric N Olson
Sep 30, 2017·Nature Reviews. Neurology·Christopher E NelsonCharles A Gersbach
Dec 25, 2016·American Journal of Physiology. Lung Cellular and Molecular Physiology·Juan SongMachteld N Hylkema
Aug 16, 2017·Human Gene Therapy·Claudio MussolinoToni Cathomen
Feb 21, 2018·Journal of Neurology, Neurosurgery, and Psychiatry·George K Tofaris, Noel J Buckley
Jul 6, 2018·Annual Review of Phytopathology·Thorsten LangnerKhaoula Belhaj
Jun 1, 2018·Annual Review of Genomics and Human Genetics·Liad Holtzman, Charles A Gersbach
Nov 30, 2018·PloS One·Ryan K ShultzabergerJohn Dresios
Dec 28, 2018·Nucleic Acids Research·Jonathan M HaldemanChristopher B Newgard
Mar 28, 2019·Journal of Inherited Metabolic Disease·Martijn G S RuttenMaaike H Oosterveer
May 31, 2019·Nature Reviews. Molecular Cell Biology·Adrian Pickar-Oliver, Charles A Gersbach
Aug 3, 2017·The EMBO Journal·Mareike AlbertWieland B Huttner
May 3, 2016·Current Opinion in Hematology·Franco Izzo, Dan A Landau
Jun 22, 2017·Annual Review of Biomedical Engineering·Joshua B BlackCharles A Gersbach
Jan 13, 2018·GeroScience·Dustin R MasserWillard M Freeman
Jan 30, 2020·International Journal of Molecular Sciences·Yongxing FangClaudio Mussolino
Feb 7, 2020·SLAS Discovery·Ami KabadiLauren Drowley
Jan 12, 2020·Nucleic Acids Research·Julian A N M HalmaiKyle D Fink
Apr 4, 2020·The International Journal of Neuroscience·Arash SalmaninejadMajid Mojarrad
Feb 20, 2020·Current Opinion in Allergy and Clinical Immunology·Ioana AgacheLiliana Rogozea
Jan 11, 2020·AIMS Genetics·Asaad M Mahmood, Jim M Dunwell
Dec 11, 2019·Briefings in Functional Genomics·Wen-Di PeiYang Yu

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

CRISPR Ribonucleases Deactivation

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on mechanisms that underlie deactivation of CRISPR ribonucleases. Here is the latest research.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.